News2 months ago
OpenAI’s Sam Altman Reveals He Was Hospitalized After Experimenting With a GLP-1 Drug
Sam Altman opened up about his experience using semaglutide, a GLP-1 drug sold under the names Wegovy and Ozempic, and the medicine didn’t work for him....